Acurx PharmaceuticalsACXP
13F holders, Q1 2024 (March 31)26holders
$2.44avg. 13F price*
At the end of Q1 2024, 26 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings. The largest holders were Vanguard Group Inc. ($1.2M), Prospect Financial Services LLC ($668K) and Geode Capital Management, LLC ($285K).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $214K |
| Exits | 5 | $97K |
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | Add +21.0% | 491,687 | $1.2M |
| Prospect Financial Services LLC | 0.55% | Add +6.9% | 272,850 | $668K |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 116,352 | $285K |
| Osaic Holdings, Inc. | 0.00% | No change | 57,250 | $140K |
| State Street Corp. | 0.00% | Add +52.2% | 43,466 | $106K |
| LPL Financial LLC | 0.00% | Add +194.1% | 40,235 | $99K |
| Susquehanna International Group, LLP | 0.00% | Reduce -30.1% | 37,438 | $92K |
| Morgan Stanley | 0.00% | Add +63.0% | 26,401 | $65K |
| BlackRock Inc. | 0.00% | Reduce -70.4% | 18,688 | $46K |
| Northern Trust Corp. | 0.00% | No change | 17,153 | $42K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 18,656 | $40K |
| Lanark Financial, Inc. | 0.00% | New | 14,000 | $34K |
| Group One Trading LLC | 0.00% | New | 13,481 | $33K |
| XTX Topco Ltd | 0.00% | New | 13,041 | $32K |
| Two Sigma Investments, LP | 0.00% | New | 12,986 | $32K |
| Simplex Trading, LLC | 0.00% | New | 10,729 | $26K |
| Patriot Financial Group Insurance Agency, LLC | 0.00% | New | 10,385 | $25K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 10,000 | $25K |
| Tocqueville Asset Management L.P. | 0.00% | Reduce -23.7% | 10,000 | $25K |
| Semmax Financial Advisors Inc. | 0.00% | No change | 5,879 | $12K |
| Cornerstone Planning Group LLC | 0.00% | No change | 3,344 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,868 | $7K |
| Cutler Group LLC / CA | 0.00% | Reduce -47.8% | 1,200 | $2K |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 500 | $1K |
| Wells Fargo & Company | 0.00% | Add +7.4% | 87 | $213 |
| Royal Bank of Canada | 0.00% | Reduce -30.2% | 37 | $0 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.